Intuitive Surgical (ISRG) Receives FDA Letter Following Facility Inspection
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
FDA Form 483 on Intuitive Surgical (ISRG) is 'Benign' - Canaccord Genuity
June 26, 2013 10:55 AM EDTCanaccord Genuity reiterated a Buy rating and $527 price target on Intuitive Surgical (NASDAQ: ISRG) Wednesday amid the Form 483 filing from the FDA saying it is benign.
Canaccord Genuity analyst Jason Mills said "Based on our conversations with management last night, we believe... More
